Advertisement

Topics

Boosting T Cell "Memory" May Result in Better Responses for Patients Treated With Checkpoint Blockade Immunotherapies

10:01 EDT 17 Apr 2018 | Drug Discovery Development

The study demonstrated that anti-CTLA-4 and anti- PD-1 immunotherapies together appear to enhance response rates and generate formation of memory T cells in mice vaccinated with melanoma cells.
Contributed Author: 
MD Anderson Cancer Center

Original Article: Boosting T Cell "Memory" May Result in Better Responses for Patients Treated With Checkpoint Blockade Immunotherapies

NEXT ARTICLE

More From BioPortfolio on "Boosting T Cell "Memory" May Result in Better Responses for Patients Treated With Checkpoint Blockade Immunotherapies"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...